company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,259099000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,259099000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28366000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28366000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,230733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,133543000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62581000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,196124000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34609000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2407000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2810000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,121000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,34730000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1581000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,33149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,33149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77680000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,89967000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,77100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2008.0,FY,2008-01-01,2008-12-31,2011-02-17 17:17:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,386800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,386800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,45059000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,45059000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,341741000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,172767000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,81915000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,254682000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87059000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4001000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,786000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-530000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83314000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-211852000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,295166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,295166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,295166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,170652000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.73
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,181164000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,170600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 17:29:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.73
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,102628000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,102628000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,11895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,11895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41523000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62846000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,80000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,125000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-205000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,27682000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,951000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87447000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90946000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q3,2009-07-01,2009-09-30,2010-11-02 15:45:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,92256000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,92256000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,10313000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,10313000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81943000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42705000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18288000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60993000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20950000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3504000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,184000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,264000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3056000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17894000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1092000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16802000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16802000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16802000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85128000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90159000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2009.0,Q2,2009-04-01,2009-06-30,2010-07-30 17:04:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,155976000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,155976000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,20222000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,20222000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,135754000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62825000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27177000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,722000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90724000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45030000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,174000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,442000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1050000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-782000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,44248000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17798000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26450000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26450000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26450000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178542000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186074000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,179700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,540957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,540957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,64437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,64437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,476520000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,226766000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98394000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,722000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,325882000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,150638000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,704000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1511000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2434000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1627000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,149011000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51981000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,97030000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,97030000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,97030000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178542000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186074000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,179700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,FY,2010-01-01,2010-12-31,2013-02-19 10:05:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,384981000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,384981000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,44215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,44215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,340766000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,163941000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,71217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,235158000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,105608000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,530000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1069000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1384000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-845000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,104763000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34183000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,70580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,70580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,70580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178980000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186042000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,141569000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,141569000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,16495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,16495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,125074000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57208000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25153000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82361000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42713000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,162000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,483000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-427000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-106000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,42607000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14734000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27873000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27873000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,27873000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178980000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,186042000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,174200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q3,2010-07-01,2010-09-30,2011-10-31 16:22:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,243412000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,243412000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,27720000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,27720000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,215692000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,106733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46064000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,152797000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,62895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,368000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,586000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-739000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,62156000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19449000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178004000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,185150000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,181400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,125834000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,125834000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13721000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13721000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,112113000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56098000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32325000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,158000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,336000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-242000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,32083000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10310000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21773000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21773000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21773000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,178004000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,185150000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,181400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q2,2010-04-01,2010-06-30,2011-08-03 15:07:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,117578000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,117578000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,13999000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,13999000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103579000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50635000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22374000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,73009000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,210000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-537000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-497000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30073000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9139000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20934000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20934000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20934000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88506000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92090000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2010.0,Q1,2010-01-01,2010-03-31,2011-05-04 17:21:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,227559000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,227559000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28798000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28798000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,198761000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,86566000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34398000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2322000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,123391000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,75370000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,183000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,220000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1329000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1292000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,74078000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25908000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48170000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,183220000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,191806000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,783431000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,783431000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,93140000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,93140000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,690291000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,308176000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,137421000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,382000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13486000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,459465000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,230826000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1911000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2281000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1158000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,229668000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,54353000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,175315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,175315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,175315000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,183220000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.96
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,191806000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,FY,2011-01-01,2011-12-31,2014-02-10 16:43:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.96
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,555872000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,555872000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,64342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,64342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,491530000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,221610000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,103023000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,277000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11164000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,336074000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,155456000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,605000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1691000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-952000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,134000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,155590000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28445000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,127145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,127145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,127145000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,183706000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.69
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.69
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,711848000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,711848000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,84564000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,84564000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,627284000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,284435000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,130200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,277000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11886000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,426798000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,200486000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,779000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2133000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2002000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-648000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,199838000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46243000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,153595000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,153595000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,153595000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,183706000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,204047000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,204047000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,23369000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,23369000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,180678000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77572000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36567000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,236000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,114479000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,66199000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,204000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,523000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-841000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-522000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,65677000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,107000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,65570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,65570000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,183706000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192161000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q3,2011-07-01,2011-09-30,2012-10-29 13:26:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,351825000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,351825000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,40973000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,40973000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,310852000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,144038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,66456000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,173000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10928000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,221595000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,89257000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,401000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1168000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-111000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,656000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,89913000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28338000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,182962000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,191187000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,649370000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,649370000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,77690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,77690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,571680000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,264071000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,118786000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,173000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11650000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,394680000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,177000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,737000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2093000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-232000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,176768000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,60870000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,115898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,115898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,115898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,182962000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,191187000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,185699000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,185699000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,21745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,21745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,163954000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,78180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35646000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,114930000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,49024000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,203000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,772000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-506000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,63000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49087000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14342000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,34745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34745000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,182962000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,191187000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,182900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q2,2011-04-01,2011-06-30,2012-07-27 13:45:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,589505000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,589505000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69666000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,69666000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,519839000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,241989000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,106830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10650000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,359538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,160301000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,692000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1657000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1502000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-537000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,159764000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56838000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102926000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,102926000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,102926000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,181724000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190366000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,178900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,166126000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,166126000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,19228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,19228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,146898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30810000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9928000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,106665000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,40233000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,198000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,396000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,395000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,593000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,40826000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13996000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,181724000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,190366000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,178900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:14:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,320526000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,320526000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,33147000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,33147000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287379000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,112624000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,63409000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,105000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3365000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,179503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,107876000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1181000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,966000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-391000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-606000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,107270000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26298000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80972000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,80972000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,80972000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190461000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,198501000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1134114000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1134114000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,72837000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,72837000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1061277000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,384678000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,222732000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,22812000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,656939000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,404338000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7402000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1838000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1208000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6772000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,397566000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,142744000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,254822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,254822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,254822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,190461000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,198501000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,FY,2012-01-01,2012-12-31,2015-02-06 16:37:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,813588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,813588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39690000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,773898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,272054000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,159323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,312000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19447000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,477436000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,296462000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,872000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-817000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,290296000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,116446000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,173850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,173850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,173850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,193353000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201142000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,192000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1041147000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1041147000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,68488000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,68488000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,972659000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,358620000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,193721000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,21769000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,600827000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,371832000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6404000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1092000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2146000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7458000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,364374000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,142354000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,222020000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,222020000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,222020000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,193353000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201142000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,192000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.15
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,294136000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,294136000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-20191000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-20191000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,314327000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,89957000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54280000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,967000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,171608000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,142719000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1855000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,317000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-416000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1954000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,140765000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,48586000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92179000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,92179000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,92179000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,193353000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201142000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.46
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,192000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q3,2012-07-01,2012-09-30,2013-10-25 16:53:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,519452000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,519452000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59881000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59881000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,459571000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,182097000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,105043000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,208000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,18480000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,305828000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,153743000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4366000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,555000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-401000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,149531000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,67860000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,81671000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,81671000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,81671000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,197051000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,951058000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,951058000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,112048000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,112048000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,839010000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,346235000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,176008000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,21038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,543698000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,295312000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4753000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1298000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2571000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6026000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,289286000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,93875000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,195411000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,195411000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,195411000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,197051000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,274719000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,274719000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,31613000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,31613000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,243106000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,94855000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59635000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4807000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,159401000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,83705000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2079000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,282000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-186000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1983000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,81722000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45464000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188575000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,197051000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,190800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q2,2012-04-01,2012-06-30,2013-07-26 16:21:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,862038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,862038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,102180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,102180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,759858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,329560000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,152019000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,17231000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,499227000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,260631000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2877000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2891000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3980000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,256651000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,62753000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,193898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,193898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,193898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,185682000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194560000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,189200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,244733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,244733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,28268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,28268000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,216465000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,87242000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45408000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13673000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,146427000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,70038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2287000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,273000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2229000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,67809000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22396000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45413000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45413000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45413000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,185682000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194560000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,189200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2012.0,Q1,2012-01-01,2012-03-31,2013-04-30 14:32:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1551346000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1551346000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,177556000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,177556000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1373790000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,489720000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,317093000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1440000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,33521000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,845780000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,528010000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4112000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3346000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-975000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1741000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,526269000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,273374000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,252895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,252895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,252895000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195532000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.29
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199712000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.27
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,FY,2013-01-01,2013-12-31,2017-01-19 17:14:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.29
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,441909000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,441909000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51552000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51552000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,390357000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,134819000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,85785000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1128000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,33521000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-6974000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,252285000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,138072000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,807000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1553000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-841000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-95000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,137977000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,156969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18992000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18992000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18992000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195532000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199712000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1109437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1109437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,126004000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,126004000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,983433000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,354901000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,231308000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,312000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6974000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,593495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,389938000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3305000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1793000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-134000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1646000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,388292000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,116405000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,271887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,271887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,271887000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195662000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199711000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.39
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1429963000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1429963000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,159151000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,159151000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1270812000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,467525000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,294717000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10339000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,772998000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,497814000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4486000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2759000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-525000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2252000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,495562000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,142703000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,352859000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,352859000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,352859000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195662000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199711000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.8
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,400405000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,400405000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51358000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51358000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,349047000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,122886000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,88209000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2573000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,213772000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,135275000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1078000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,638000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-547000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-987000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,134288000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,40503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93785000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,93785000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93785000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195662000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199711000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 16:52:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,709032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,709032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,74646000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,74646000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,634386000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,232015000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,143099000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,208000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4401000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,379723000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,254663000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2227000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1155000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,413000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-659000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,254004000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,75902000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,178102000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,178102000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,178102000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195247000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199299000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1323694000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1323694000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,87602000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,87602000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1236092000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,434596000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,260788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8733000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,730834000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,505258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5263000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2438000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-394000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3219000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,502039000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,150786000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,351253000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,351253000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,351253000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195247000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199299000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.8
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,370091000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,370091000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39377000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39377000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,330714000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,123189000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68563000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1167000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,193023000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,137691000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1056000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,718000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-90000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-428000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,137263000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41378000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,95885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,95885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,95885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,195247000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199299000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q2,2013-04-01,2013-06-30,2014-07-25 12:19:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1228322000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1228322000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,79838000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,79838000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1148484000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,406262000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,251860000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,26300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,12373000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,697212000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,451272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6286000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2002000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-490000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4774000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,446498000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,154872000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,291626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,291626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,291626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,194771000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199057000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,338941000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,338941000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,35269000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,35269000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,303672000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,108826000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74536000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,104000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3234000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,186700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,116972000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1171000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-231000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,116741000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34524000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,82217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,82217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,82217000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,194771000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,199057000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,195800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2013.0,Q1,2013-01-01,2013-03-31,2014-04-25 15:32:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2234000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2234000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,174000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,174000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2060000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,630000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,514000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,12000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,20000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1191000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,869000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,872000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,215000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,657000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,657000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,657000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,198000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.32
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,202000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,197900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,FY,2014-01-01,2014-12-31,2017-02-16 17:22:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.32
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,599743000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,599743000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49577000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,49577000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,550166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,183567000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,129328000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-10292000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,8536000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15038000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,20000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,346177000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,203989000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,567000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1823000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1245000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,205234000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51814000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,153420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,153420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,153420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,198000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,202000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.76
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,197900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,555146000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,555146000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,51858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,51858000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,503288000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,157665000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,100661000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8303000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,266629000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,236659000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,655000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2250000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2045000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-450000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,236209000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,58478000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,177731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,177731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,177731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,198052000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.9
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201313000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,197500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 16:41:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.9
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1634257000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1634257000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,124423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,124423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1509834000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,446433000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,384672000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,10292000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3464000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-38000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,844823000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,665011000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2433000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6177000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1989000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1755000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,666766000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,163186000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,503580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,503580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,503580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,198052000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.55
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201313000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,197500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.55
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2076166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2076166000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,175975000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,175975000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1900191000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,581252000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,470457000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,11420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,36985000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-7012000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1097108000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,803083000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3240000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7730000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1660000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,804743000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,320155000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,484588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,484588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,484588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,198052000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.45
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201313000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,197500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.45
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1079111000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1079111000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,72565000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,72565000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1006546000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,288768000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,284011000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1989000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3464000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-38000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,578194000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,428352000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1778000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3927000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,56000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2205000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,430557000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,104708000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,325849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,325849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,325849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,197880000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.65
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201524000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,198200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.65
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1921425000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1921425000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,175475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,175475000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1745950000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,546473000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,458005000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,36985000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4439000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1044251000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,701699000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3663000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6118000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1332000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1123000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,702822000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,302180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,400642000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,400642000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,400642000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,197880000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201524000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,198200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,512495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,512495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,39626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,39626000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,472869000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,159477000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,92554000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1989000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,254020000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,218849000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,715000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1714000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1202000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-203000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,218646000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52151000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,166495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,166495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,166495000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,197880000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201524000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,198200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q2,2014-04-01,2014-06-30,2015-07-31 13:50:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1779021000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1779021000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,175226000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,175226000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1603795000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,510185000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,434014000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1336000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,36985000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3272000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4006000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,983254000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,620541000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4004000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5122000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-220000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,898000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,621439000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,291407000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,330032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,330032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,330032000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,197797000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.67
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201804000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.67
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.67
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,566616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,566616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,32939000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,32939000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,533677000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,129291000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191457000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,3464000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-38000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,324174000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,209503000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1063000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2213000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1258000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2408000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,211911000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52557000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,159354000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,159354000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,159354000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,197797000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,201804000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.79
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,196700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2014.0,Q1,2014-01-01,2014-03-31,2015-04-24 16:06:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2602500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2604000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,233100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,233100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2370900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,862600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,709500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,155800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,42100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,64200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1834200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,536700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,47800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,498100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,353700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,144400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,144400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,144400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,FY,2015-01-01,2015-12-31,2018-02-08 16:26:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,700393000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,427000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,700820000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,57637000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,57637000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,643183000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,241581000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191063000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,83340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11363000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,18493000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,545840000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,97343000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23207000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1055000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22839000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,74504000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,66619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,66619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,66619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,213400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,215900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,212400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,665791000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,846000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,666637000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,54057000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,54057000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,612580000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212520000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,165664000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,42683000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7461000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,29684000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,458012000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,154568000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19971000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1967000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2795000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15209000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,139359000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,323116000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-183757000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-183757000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-183757000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,226228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.81
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.81
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,226900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3,2015-07-01,2015-09-30,2017-01-04 17:16:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.81
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1902107000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1073000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1903180000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,175463000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,175463000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1727717000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,621019000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,518437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,72460000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,30737000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,45707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1288360000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,439357000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24593000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1755000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15761000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,423596000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,345815000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,77781000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,77781000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,77781000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,226228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,226900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2501850000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1073000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2502923000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225040000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225040000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2277883000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,804586000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,647765000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,62168000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,8536000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,45775000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,65707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1634537000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,643346000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25160000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1744000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14516000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,628830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,397629000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,231201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,231201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,231201000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,226228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226228000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.23
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,226900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,635983000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,227000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,636210000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,52007000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,52007000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,584203000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,221383000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,131693000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,29777000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,16224000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4044000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,403121000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,181082000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3971000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2226000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2045000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3790000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,177292000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,170215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,170215000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,202234000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,204546000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,202600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:11:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1236316000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,227000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1236543000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,121406000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,121406000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1115137000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,408499000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,352773000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,29777000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23276000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,16023000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,830348000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,284789000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4622000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5110000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1040000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-552000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,284237000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,22699000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,261538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,261538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,261538000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,202234000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,204546000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,202600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2391205000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,227000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2391432000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,222841000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,222841000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2168591000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,749731000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,582762000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,27788000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,8536000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,38314000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36023000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1443154000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,725437000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5844000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9183000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3096000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,243000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,725680000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,132991000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,592689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,592689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,592689000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,202234000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.97
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,204546000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.92
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,202600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.97
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,600333000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,600333000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69399000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,69399000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,530934000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187116000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,221080000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,7052000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11979000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,427227000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,103707000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,651000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2884000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1005000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3238000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,106945000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15622000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,91323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,91323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,91323000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,199361000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.46
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,202034000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,198500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1,2015-01-01,2015-03-31,2016-04-29 16:29:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.46
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2267717000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2267717000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,210460000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,210460000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2057257000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,687825000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,543623000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,8536000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,22090000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,31979000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1294053000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,763204000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2588000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8671000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2253000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3830000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,767034000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,178065000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,588969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,588969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,588969000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,199361000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.97
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,202034000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.92
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,198500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.97
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3084100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3084100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2825800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,953000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,757200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,324500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,35700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2158400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,667400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,96900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,10900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-91200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,576200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,176800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,399400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,399400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,399400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.78
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.76
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,FY,2016-01-01,2016-12-31,2019-02-06 09:03:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.78
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,833100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,831100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,68300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,68300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,762800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,258000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,206200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,635400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,127400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,104200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,93400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,798000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,799000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,71000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,71000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,728000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,230000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,82000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,41000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,549000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,179000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,159000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,65000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 16:06:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2251000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2253000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,190000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,190000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2063000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,695000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,551000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,244000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,31000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1523000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,540000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,72000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,472000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,166000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,306000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,306000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,306000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.37
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.37
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2951393000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2427000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2953820000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,247637000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,247637000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2706183000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,936581000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,742063000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,327340000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13363000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,49493000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2068840000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,637343000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,95207000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9423000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5055000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-90839000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,546504000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,173885000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,372619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,372619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,372619000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.56
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.56
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.56
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,753000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,753000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,693000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,232000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,180000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,81000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,498000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,195000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,170000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,50000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,120000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,120000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,120000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 16:10:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1453000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1454000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,119000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1335000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,465000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,356000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,162000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-10000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,974000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,361000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,313000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,101000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2819184000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2273000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2821457000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,230694000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,230694000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2590763000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,919101000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,712727000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,288023000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19824000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,38177000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1977852000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,612911000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,91178000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6390000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1260000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-86048000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,526863000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,432001000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94862000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,94862000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,94862000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.33
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.33
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,700000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,701000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,59000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,59000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,642000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,233000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,176000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,81000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-15000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,476000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,166000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,143000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,92000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,92000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,92000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,225000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,227000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 16:07:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2702167000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2704667000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,222701000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,222701000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2481966000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,908484000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,664420000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,236800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,36048000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,37221000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1882973000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,598993000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,71149000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6616000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-305000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-64838000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,534155000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,389078000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,145077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,145077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,145077000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,225000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,227000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3551100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3551100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,454200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,454200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3096900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1094400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,878400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,31000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,104600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,41000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2469500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,627400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,98400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,547800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,104500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,443300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,443300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,443300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.98
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.97
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,FY,2017-01-01,2017-12-31,2020-02-04 06:30:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.98
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,911000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,909700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,144600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,144600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,765100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,296400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,265000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,9200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,656500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,108600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-19300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,89300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,59300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.14
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,858800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,859100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,157000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,157000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,702100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,270600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,72000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,622000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,80100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,58200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-19800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,78000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,78000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,78000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3,2017-07-01,2017-09-30,2018-10-24 16:27:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2640100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2641400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,309600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,309600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2331800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,798000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,613400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,240100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,31000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,98700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,31800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1813000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,518800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,73300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-60300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,458500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,45200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,413300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,413300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,413300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.83
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.85
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3473200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3472500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,377900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,377900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3094600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1056000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,819600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,116000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,99700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2448400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,646200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,98200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-83500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,562700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,506700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,506700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,506700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.23
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.26
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,912200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,912700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,83600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,83600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,829100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,265600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,198200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,31000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,24600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,602400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,226700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,4500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,206300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,41100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,165200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,165200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,165200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 16:40:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1781300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1782300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1629700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,527400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,417700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,160100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,31000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,28100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1191000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,438700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,400300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,65000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,335300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,335300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,335300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3412400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3412400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,291900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,291900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3120500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1015400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,818900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,322600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,116000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,28700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,73800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2375400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,745100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,97200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-81600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,663500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,140800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,522700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,522700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,522700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.33
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.3
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.33
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,869100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,869600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,69000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,800600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,261800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,219500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,3500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,588600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,212000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,194000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,23900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,170100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,170100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.76
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.75
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 16:05:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3253200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3252700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,268300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,268300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2984400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,981800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,800700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,323500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,85000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,25800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,54200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2271000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,713400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,96400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-86200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,627200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,149700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,477500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,477500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,477500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.13
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,226200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.1
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.13
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4131200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4131200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,374300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,374300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3756900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1111800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1913400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,25500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,116500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3487300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,269600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,98200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-27400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,242200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,164600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,77600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,77600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,77600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.35
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,221700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,FY,2018-01-01,2018-12-31,2020-02-04 06:30:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.35
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1128800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1128800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,96800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,96800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1032000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,318700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,584900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,988300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-54100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-76600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,221700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1026500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1026500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,90600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,90600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,935900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,258700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,174800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,53500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,577300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,358600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,342100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,330900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.47
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3,2018-07-01,2018-09-30,2019-10-23 07:56:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.48
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3002400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3002400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,277500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,277500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2724900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,793100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1328500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,240100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,110900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2499000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,225900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,73700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,119400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,275100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,152500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,122600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,122600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,122600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3913400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3912100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,422100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,422100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3490000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1089500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1593500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,32300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,120100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3155500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,334500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,98800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,125000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,364400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,211800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,152600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.67
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1045000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1045000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,949700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,277300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,977100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,10600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1349800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-400100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-418600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,38800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-457400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-457400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-457400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.05
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.05
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2,2018-04-01,2018-06-30,2019-07-24 08:00:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.05
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1975900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1975900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,186900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,186900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1789000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,534400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1153700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,160100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,16100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,57400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1921700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-132700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,113500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,65700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-67000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,141300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-208300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-208300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-208300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.93
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.94
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.93
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3745700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3744700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,488500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,488500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3256200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1101400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1614400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,70300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3200200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,99200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,123600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,24500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,80500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,180800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-100300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-100300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-100300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.45
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.45
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.45
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,930900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,930900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,839300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,257100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,176600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,52700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,571900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,267400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,84200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,351600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,102500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,249100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,249100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.12
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,223700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.11
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 08:51:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.12
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3612900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3612400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,476800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,476800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3135600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1089700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,835500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,31000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,86300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,90200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2452800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,682800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,99000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,120400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,705400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,183100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,522300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,522300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,522300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,222100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,223700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.33
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,222400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.34
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1384300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1384300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,114300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,114300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1270000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,381000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,269600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,729000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,541000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,49700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,33000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,61000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,602000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-287000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,889000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,889000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,889000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.97
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4991100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4991100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,394500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,394500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4596600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1261100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,881900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,309600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,12000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,11600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2476200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2120400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,77800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,58400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2178800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-225500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2404300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2404300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2404300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,10.77
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.7
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,FY,2019-01-01,2019-12-31,2020-02-04 06:30:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.77
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3606800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3606800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,280200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,280200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3326600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,880100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,612300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,235700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,7200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1747200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1579400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,56100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1576800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1515300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1515300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1515300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.77
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.73
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.77
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4735600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4735600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,377000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,377000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4358600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1198800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1197200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,315700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,12800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2735500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1623100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,80600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1543900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,73600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1470300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1470300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1470300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.57
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.55
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.57
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1263100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1263100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,95200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1167900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,299300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,232900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,75600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,29800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,637900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,530000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,535500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,67900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,467600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,467600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,467600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.09
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,224500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.08
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q3,2019-07-01,2019-09-30,2019-10-23 07:56:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.09
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2343700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2343700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,185000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,185000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2158700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,580800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,379400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,160100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-22600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1109300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1049400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,38200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,27600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1041300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1047700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1047700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1047700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.68
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.65
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.68
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4499000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4499000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,372400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,372400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4126600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1158200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1139100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,21000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,36500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2674900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1451700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,87300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-20600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1350500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1333600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1333600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1333600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.96
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.94
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.96
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1203300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1203300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,99200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1104100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,299300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,183500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,6100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,571500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,532600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-14900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,499500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,459800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,459800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,459800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,224200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.05
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.04
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,224300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q2,2019-04-01,2019-06-30,2019-07-24 08:00:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.05
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1140400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1140400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,85800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,85800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1054600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,281500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,80000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,9100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-28700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,537800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,516800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,42500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,541800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-46100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,587900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,587900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,587900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.61
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 07:23:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.63
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4340700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4340700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,368500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,368500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3972200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1136200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1932700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,320100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,29100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,35100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3453200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,519000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,94000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-86600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,432400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,416400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,416400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,416400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,223800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.86
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,225500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.85
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,223500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.86
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5295500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5295500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,420400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,420400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4875100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1299500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,886900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,303300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,40200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,46100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2576000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2299100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,83700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,32600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2300600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-73400000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2374000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2374000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2374000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,221600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.66
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.59
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,221300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.66
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1444800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1444800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,111700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,111700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1333100000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,319900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,200900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73700000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,37300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,5800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,637600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,695500000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25800000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5200000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31900000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,663600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,106000000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,557600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,557600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,557600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,221600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.52
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,222600000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.5
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,221300000.0
Alexion Pharmaceuticals Inc,ALXN,M1YXUUZR0EIMU8T0EM75,0000899866,2020.0,Q1,2020-01-01,2020-03-31,2020-05-06 07:23:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.52
